Ann K. Daly

Active 1984–2025

Also published as
Ann K Daly
145
Papers
29,596
Citations
96
h-index
143
i10-index

Citations

Citations per year for Ann K. Daly1983: 1 citations1984: 2 citations1985: 3 citations1986: 4 citations1987: 4 citations1988: 4 citations1989: 2 citations1990: 1 citations1991: 1 citations1992: 2 citations1993: 10 citations1994: 16 citations1995: 43 citations1996: 44 citations1997: 53 citations1998: 60 citations1999: 106 citations2000: 114 citations2001: 155 citations2002: 191 citations2003: 210 citations2004: 258 citations2005: 248 citations2006: 256 citations2007: 204 citations2008: 188 citations2009: 205 citations2010: 204 citations2011: 236 citations2012: 181 citations2013: 204 citations2014: 182 citations2015: 233 citations2016: 233 citations2017: 197 citations2018: 149 citations2019: 548 citations2020: 608 citations2021: 729 citations2022: 770 citations2023: 599 citations2024: 1,067 citations2025: 549 citations2026: 22 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,583 citing papers, 22.9% of this breakdownUnited Kingdom: 971 citing papers, 8.6% of this breakdownChina: 911 citing papers, 8.1% of this breakdownGermany: 661 citing papers, 5.8% of this breakdownItaly: 600 citing papers, 5.3% of this breakdownSpain: 412 citing papers, 3.6% of this breakdownJapan: 408 citing papers, 3.6% of this breakdownFrance: 356 citing papers, 3.1% of this breakdownSweden: 343 citing papers, 3% of this breakdownCanada: 327 citing papers, 2.9% of this breakdownNetherlands: 268 citing papers, 2.4% of this breakdownAustralia: 255 citing papers, 2.3% of this breakdown
0%22.9%Other 28.4%

Fields

  • Medicine53.9%
  • Pharmacology, Toxicology and Pharmaceutics25.8%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Immunology and Microbiology1.6%
  • Computer Science0.9%
  • Nursing0.6%
  • Other2.9%

Topics

  • Liver Disease Diagnosis and Treatment10.3%
  • Pharmacogenetics and Drug Metabolism9.3%
  • Drug Transport and Resistance Mechanisms3.9%
  • Drug-Induced Hepatotoxicity and Protection3.6%
  • Diet, Metabolism, and Disease2.7%
  • Hepatocellular Carcinoma Treatment and Prognosis2.1%
  • Other68.1%

Coauthors

All papers

Open in search
  1. NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger and 10 more - Nature 2021 cited by 1,280

  2. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 cited by 454

  3. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 514

  4. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier and 35 more - Journal of Hepatology 2021 cited by 353

  5. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas and 130 more - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 187

  6. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

    Authors: , , , , , , , , , , , - Clinical Pharmacology & Therapeutics 2011 cited by 1,017

  7. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen and 138 more - Nature Metabolism 2024 cited by 229

  8. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 275

  9. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures

    Authors: , , , , , , , , , , , , - Nature Metabolism 2023 cited by 150

  10. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas J. Hand, Ching‐Ti Liu, Michelle T. Long, Jie Yao, Matthew J. Budoff, Jingyi Tan, Xiaohui Li, Henry J. Lin, Yii‐Der Ida Chen, Kent D. Taylor, Ruey‐Kang R. Chang, Ronald M. Krauss, Sílvia Vilarinho, Joseph Brancale, Jonas B. Nielsen, Adam E. Locke, Marcus B. Jones, Niek Verweij, Aris Baras, K. Rajender Reddy, Brent A. Neuschwander‐Tetri, Jeffrey B. Schwimmer, Arun J. Sanyal, Naga Chalasani, Kathleen A. Ryan, Braxton D. Mitchell, Dipender Gill, Andrew D. Wells, Elisabetta Manduchi, Yedidya Saiman, Nadim Mahmud, Donald R. Miller, Peter D. Reaven, Lawrence S. Phillips, Sumitra Muralidhar, Scott L. DuVall, Jennifer Lee, Themistocles L. Assimes, Saiju Pyarajan, Kelly Cho, Todd L. Edwards, Scott M. Damrauer, Peter W.F. Wilson, J. Michael Gaziano, Christopher J. O’Donnell, Amit V. Khera, Struan F.A. Grant, Christopher D. Brown, Philip S. Tsao, Danish Saleheen, Luca A. Lotta, Lisa Bastarache, Quentin M. Anstee, Ann K. Daly, James B. Meigs, Jerome I. Rotter, Julie A. Lynch, VA Million Veteran Program, Daniel J. Rader, Benjamin F. Voight, Kyong‐Mi Chang - Nature Genetics 2022 cited by 194

  11. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

    Authors: , , , , , , , , , - Journal of Hepatology 2014 cited by 534

  12. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 617

  13. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 cited by 160

  14. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , - JHEP Reports 2022 cited by 103

  15. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2001 cited by 2,161

  16. Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†

    Authors: , , , , , , , , , , , , , , - Hepatology 2010 cited by 649

  17. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Dabbas, Déirdre Kelly, Valério Nobili, Connor A. Emdin, Madison Fairey, Glenn S. Gerhard, Guðný Eiríksdóttir, Melissa E. Garcia, Vilmundur Guðnason, Tamara B. Harris, Lauren J. Kim, Lenore J. Launer, Michael A. Nalls, Albert V. Smith, Jeanne M. Clark, Rubén Hernáez, Wei-Tang Kao, Braxton D. Mitchell, Alan R. Shuldiner, Laura M. Yerges‐Armstrong, Ingrid B. Borecki, J. Jeffrey Carr, Mary F. Feitosa, Jun Wu, Johannah L. Butler, Caroline S. Fox, Joel N. Hirschhorn, Udo Hoffmann, Shih‐Jen Hwang, Joseph M. Massaro, Christopher J. O’Donnell, Cameron D. Palmer, Dushyant V. Sahani, Elizabeth K. Speliotes, Xiuqing Guo, Jochen Hampe, Matthew Hickman, Lena Heintz, Christian Hudert, Harriet Hunter, Matt Kelly, Julia Kozlitina, Marcin Krawczyk, Frank Lammert, Claudia Langenberg, Joel E. Lavine, Lin Li, Hong Kai Lim, Rohit Loomba, Panu K. Luukkonen, Phillip E. Melton, Trevor A. Mori, Nicholette D. Palmer, Constantinos A. Parisinos, Sreekumar Pillai, Faiza Qayyum, Matthias Reichert, Stefano Romeo, Jerome I. Rotter, Yu Ri Im, Nicola Santoro, Clemens Schafmayer, Elizabeth K. Speliotes, Stefan Stender, Felix Stickel, Christopher D. Still, Pavel Strnad, Kent D. Taylor, Anne Tybjærg‐Hansen, Giuseppina Rosaria Umano and 10 more - Journal of Hepatology 2020 cited by 137

  18. Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 176

  19. Pharmacogenomics in practice: a review and implementation guide

    Authors: , , , , , - Frontiers in Pharmacology 2023 cited by 92

  20. A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sylvie Naveau, Pascal Perney, Munir Pirmohamed, Helmut K. Seitz, Michael Soyka, Felix Stickel, Andrew Thompson, Mark Thursz, Eric Trépo, Timothy R. Morgan, Devanshi Seth - Journal of Hepatology 2021 cited by 80

  21. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2009 cited by 1,043

  22. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mariam Molokhia, Munir Pirmohamed, Elizabeth E. Powell, Shengying Qin, José Serrano, Camilla Stephens, Andrew Stolz, Mia Wadelius, Paul B. Watkins, Aris Floratos, Yufeng Shen, Matthew R. Nelson, Thomas Urban, Ann K. Daly - Gastroenterology 2016 cited by 221

  23. Genome‐wide Association Study and Meta‐analysis on Alcohol‐Associated Liver Cirrhosis Identifies Genetic Risk Factors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John B. Whitfield, Timothy R. Morgan, Devanshi Seth - Hepatology 2020 cited by 103

  24. A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pär Hallberg, Nelia Hernández, Luisa Ibáñez, Gerd A. Kullak‐Ublick, Tarja Laitinen, Dominique Larrey, M. Isabel Lucena, Anke H. Maitland‐van der Zee, Jennifer Martin, Dick Menzies, Mariam Molokhia, Munir Pirmohamed, Shengying Qin, Mia Wadelius - Gastroenterology 2019 cited by 134